Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Ozempic (semaglutide) is a subcutaneous injection used in people with type 2 diabetes. It may cause mild side effects, such as abdominal pain, or more serious side effects, such as diabetic ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Ozempic made headlines after a study came out linking this and similar medications like Wegovy to an eye condition that can cause irreversible damage and permanent vision loss, including total ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...

He also published one of the first case series that found semaglutide, the active ingredient in Ozempic, to effectively ... disorder in the United States is 2%,” he said.

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

The maximum semaglutide dose for weight loss is 2.4 milligrams (mg) per week ... The popularity of semaglutide, the active ingredient in Ozempic and Wegovy, has skyrocketed in recent years.

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.